Kenyon Lawrence A

Avg. Two Year Performance

(52%) Avg. Purchase Return
(23%) Compound
6% Avg. Sale Return
3% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return11%(7%)(22%)(22%)(52%)
Purchase Success Rate2 of 31 of 30 of 30 of 30 of 3
Average Sale Return(< 1%)2%1%3%6%
Sale Success Rate1 of 43 of 42 of 43 of 42 of 4

Outlook Therapeutics, Inc.

Other » Other

CHIEF FINANCIAL OFFICER, Director:

Holdings: 5.95K shares

Sentiment

Insider Trading Sentiment: Accumulate

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Alfacell Corp.

Other » Other

President, CEO and CFO:

Holdings: 25.0K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

NeoPharm, Inc.

Drugs » Biotechnology

CFO and Secretary:

Holdings: shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Arno Therapeutics, Inc

Drugs » Biotechnology

Chief Financial Officer:

Holdings: shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Par Pharmaceutical Companie...

Drugs » Drugs - Generic

:

Holdings: 14.34K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--